INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 137 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,316 | -65.4% | 769 | -58.9% | 0.02% | -65.2% |
| Q2 2023 | $70,181 | +0.8% | 1,869 | 0.0% | 0.05% | +2.2% |
| Q1 2023 | $69,658 | +6.8% | 1,869 | 0.0% | 0.04% | 0.0% |
| Q4 2022 | $65,209 | -37.9% | 1,869 | 0.0% | 0.04% | -40.8% |
| Q3 2022 | $105,000 | +8.2% | 1,869 | 0.0% | 0.08% | +15.2% |
| Q2 2022 | $97,000 | -28.7% | 1,869 | 0.0% | 0.07% | -19.5% |
| Q1 2022 | $136,000 | -38.5% | 1,869 | 0.0% | 0.08% | -36.4% |
| Q4 2021 | $221,000 | -12.0% | 1,869 | 0.0% | 0.13% | -14.0% |
| Q3 2021 | $251,000 | -17.2% | 1,869 | 0.0% | 0.15% | -15.3% |
| Q2 2021 | $303,000 | +80.4% | 1,869 | -11.0% | 0.18% | +70.2% |
| Q1 2021 | $168,000 | +50.0% | 2,099 | +1.6% | 0.10% | +38.7% |
| Q4 2020 | $112,000 | +202.7% | 2,066 | +9.8% | 0.08% | +177.8% |
| Q3 2020 | $37,000 | -17.8% | 1,882 | -11.6% | 0.03% | -20.6% |
| Q2 2020 | $45,000 | +246.2% | 2,130 | +96.9% | 0.03% | +209.1% |
| Q1 2020 | $13,000 | -18.8% | 1,082 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $16,000 | +14.3% | 1,082 | 0.0% | 0.01% | +10.0% |
| Q3 2019 | $14,000 | -12.5% | 1,082 | +9.1% | 0.01% | -16.7% |
| Q2 2019 | $16,000 | -5.9% | 992 | 0.0% | 0.01% | -7.7% |
| Q1 2019 | $17,000 | +750.0% | 992 | +747.9% | 0.01% | +550.0% |
| Q4 2018 | $2,000 | -33.3% | 117 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | -40.0% | 117 | -33.1% | 0.00% | -50.0% |
| Q2 2018 | $5,000 | +25.0% | 175 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $4,000 | +100.0% | 175 | +75.0% | 0.00% | +50.0% |
| Q4 2017 | $2,000 | -33.3% | 100 | -16.0% | 0.00% | 0.0% |
| Q3 2017 | $3,000 | – | 119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |